Skip to main content

Table 1 Clinical data of TT-vaccinated CLL patients a

From: Dendritic Cells from Chronic Lymphocytic Leukemia Patients Are Normal Regardless of Ig V Gene Mutation Status

CLL Nr

Age/sex

Rai stage

LDT

WBC/Ald

Change of stage

Time to 1st treatment

Survival time after diagnosis

171

66/F

I

<12 mo

25.4/NA

To III at 7 y

Within 2 y

8+ y

334

54/M

II

12 mo

38.4/30.91

To IV

At 2 y

4+ y

394

53/M

I

>12 mo

15.9/10.0

None

None

3+ y

521

65/M

II

NA

NA

NA

At 5 y

5+ y

559

48/M

0

<12 mo

14/6.5

Stage I in 3.5 y

At 3 y

6+ y

561

57/M

IV

NA

13.7/9.09

NA

From diagnosis

5+ y

569

51/M

II

NA

77.9/60.0

NA

NA

Aliveb

349

59/F

0

<12 mo

10.0/NA

NA

NA

Aliveb

124

68/M

0

>12 mo

12.6/59

To IV at 5 y

Within 3 y

10 y

189

51/M

I

<12 mo

16.3/NA

To IV at 3 y

At 4 y

7+ y

567

55/F

0

>12 mo

11.4/6.4

None

None

4+ y

  1. aLDT, lymphocyte doubling time; WBC, white blood cell count; Ald, absolute lymphocyte count at time of diagnosis; NA, not analyzed.
  2. bOne visit only.